CLINICAL TRIALS PROFILE FOR LOCOID
✉ Email this page to a colleague
All Clinical Trials for LOCOID
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00693693 ↗ | Adherence to Topical Hydrocortisone 17-butyrate 0.1% (Locoid®) Using Different Vehicles in Adults With Atopic Dermatitis | Completed | Wake Forest University | Phase 4 | 2006-11-01 | The purpose of this research study is to better understand adherence to Locoid when people use it to treat atopic dermatitis. |
NCT00871208 ↗ | Trial of Treatment of Atopic Dermatitis With Concurrent Altabax® and Topical Low-Potency Corticosteroids Versus Low-Potency Corticosteroid Mono-therapy | Withdrawn | GlaxoSmithKline | Phase 4 | 2009-05-01 | This study is designed to determine whether the addition of topical Altabax (R) to a treatment regimen of topical corticosteroid therapy speeds clearance of atopic dermatitis and improves quality of life. |
NCT00871208 ↗ | Trial of Treatment of Atopic Dermatitis With Concurrent Altabax® and Topical Low-Potency Corticosteroids Versus Low-Potency Corticosteroid Mono-therapy | Withdrawn | St. Luke's-Roosevelt Hospital Center | Phase 4 | 2009-05-01 | This study is designed to determine whether the addition of topical Altabax (R) to a treatment regimen of topical corticosteroid therapy speeds clearance of atopic dermatitis and improves quality of life. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for LOCOID
Condition Name
Clinical Trial Locations for LOCOID
Trials by Country
Clinical Trial Progress for LOCOID
Clinical Trial Phase
Clinical Trial Sponsors for LOCOID
Sponsor Name